Tamodex Tamoxifen – 10 mg, 20 mg Tablets

At a Glance

Generic Name: Tamoxifen Citrate

Brand Name: Tamodex

Strength & Pack Size: 10 mg and 20 mg tablets, 1 pack / 100 tablets for each strength

Dosage Form & Route: Oral tablets for swallowing whole with water

Therapeutic Class: Selective Estrogen Receptor Modulator (SERM)

Primary Indications: Hormone receptor–positive breast cancer treatment and risk reduction in high-risk women

Typical Use in Therapy: Part of long-term adjuvant, metastatic or preventive hormonal strategies defined by oncology or breast specialists

Mode of Action: Blocks estrogen receptors in breast tissue while preserving or modulating estrogen effects in other organs

Key Benefits: Proven agent that reduces recurrence risk and can lower future breast cancer risk in selected high-risk patients

Precautions: Risk of venous thromboembolism, endometrial changes and drug interactions; requires regular follow-up

Storage: Store below 25–30 °C in the original blister, protected from moisture and out of children’s reach

Product Description

Tamodex contains tamoxifen citrate, a well-established selective estrogen receptor modulator (SERM) that remains a cornerstone of hormone receptor–positive breast cancer management. Tamodex 10 mg and Tamodex 20 mg tablets are designed for oral use and are typically taken once daily as part of a long-term plan determined by an oncologist or breast specialist. Because tamoxifen acts on hormone signalling rather than directly killing rapidly dividing cells, it is often prescribed for many years in the adjuvant setting and, in some cases, as a preventive measure in individuals at substantially increased risk of developing breast cancer.

Each Tamodex pack supplied by Generic Meds Mart contains 100 tablets of a single strength (10 mg or 20 mg). The large 1 pack / 100 tabs format is convenient for continuous daily use and helps reduce the frequency of refills for long treatment courses. The active ingredient, tamoxifen citrate, is metabolised into compounds that bind to estrogen receptors in breast tissue and block the tumour-promoting effects of estrogen. Depending on menopausal status, tumour characteristics and broader endocrine strategy, Tamodex tamoxifen tablets may be given alone or in carefully planned sequences with aromatase inhibitors or other hormonal agents.

Generic Meds Mart sources Tamodex tamoxifen tablets exclusively from licensed manufacturers and authorised distributors. Blister strips are supplied in original branded cartons, and each tablet is traceable via batch number and expiry date printed on the foil. Neutral outer packaging avoids explicit reference to breast cancer or tamoxifen, offering additional privacy during delivery. Our role is limited to structured access and logistics; all decisions regarding whether and how to use Tamodex 10 mg or Tamodex 20 mg are made by qualified healthcare professionals.

Key Uses

Tamodex tamoxifen tablets play several roles across the breast cancer care continuum and high-risk prevention strategies when supported by guidelines:

• Adjuvant treatment of hormone receptor–positive early breast cancer following surgery and, where indicated, chemotherapy or radiotherapy, to reduce the risk of recurrence and contralateral breast cancer.
• Treatment of metastatic or advanced hormone receptor–positive breast cancer in premenopausal and postmenopausal patients, often as a first-line endocrine option or as part of sequential endocrine strategies.
• Risk reduction in women at significantly increased risk of breast cancer based on personal or family history, atypical hyperplasia or other validated risk models, when tamoxifen preventive therapy is recommended in national or international guidelines.
• Selected use in men with hormone-sensitive breast cancer, where tamoxifen may be preferred as a first-line endocrine therapy under specialist oversight.

The exact indication, duration of therapy and decision to use Tamodex 10 mg, Tamodex 20 mg or a combination are always determined by the treating team, taking into account menopausal status, concurrent conditions, planned duration and concomitant medicines.

How Tamoxifen Works in Chemotherapy

Although tamoxifen is not a traditional cytotoxic agent, it is tightly integrated into many chemotherapy and systemic treatment pathways. As a SERM, tamoxifen binds to estrogen receptors in breast tissue and functions largely as an antagonist. By occupying the receptor, Tamodex tamoxifen tablets prevent estrogen from activating gene transcription programs that drive hormone-dependent tumour cell proliferation and survival.

In hormone receptor–positive breast cancer, blocking this estrogen signalling pathway significantly reduces the stimulus for growth and spread. Over time, this helps decrease the risk of recurrence after initial therapy and can control progression in metastatic disease. In some other tissues, such as bone and the endometrium, tamoxifen exerts partial agonist effects, which contributes both to benefits (for example bone density preservation) and to important risks that must be monitored (such as endometrial changes).

Dosage & Administration

Dosing of Tamodex 10 mg and 20 mg is defined by oncology or breast specialists according to local guidelines and the patient’s clinical scenario. For adjuvant hormone receptor–positive early breast cancer, typical tamoxifen schedules use a standard daily dose (commonly 20 mg) for at least 5 years, with some patients benefiting from extended courses up to 10 years or from sequences that incorporate aromatase inhibitors in postmenopausal women. In the metastatic setting, tamoxifen may be continued as long as there is clinical benefit and tolerable toxicity.

Tamodex tablets should be swallowed whole with water and taken at roughly the same time each day. They can usually be taken with or without food unless the prescriber advises otherwise. If a dose is missed, patients should follow the instructions given by their treating team rather than doubling up. Because consistent long-term use is crucial for achieving maximal risk reduction and disease control, adherence should be discussed regularly, and any barriers to daily dosing should be addressed early. Patients should never change their dose or stop Tamodex tamoxifen tablets without consulting their specialist.

Precautions

Before starting Tamodex tamoxifen tablets, clinicians review risk factors for venous thromboembolism, such as prior blood clots, inherited thrombophilia, major surgery, prolonged immobilisation, smoking and obesity. Tamoxifen increases the risk of deep vein thrombosis and pulmonary embolism, particularly around surgery or times of limited mobility, so short-term interruptions or additional preventive measures may be considered in high-risk situations.

Because tamoxifen can act as a partial estrogen agonist on the uterine lining, women with an intact uterus should be counselled to report abnormal vaginal bleeding, spotting, pelvic pain or pressure. Periodic gynaecologic evaluation may be recommended, especially in women on long-term therapy or with additional risk factors for endometrial pathology. Liver function, lipid profiles and, in some circumstances, ophthalmologic assessments may be monitored during treatment. Tamodex tamoxifen tablets can interact with certain antidepressants and other agents that influence CYP2D6 and related pathways, which may affect the formation of active tamoxifen metabolites; therefore, all prescription and non-prescription medicines should be reviewed for compatibility. Tamoxifen is typically avoided during pregnancy and breastfeeding, and reliable contraception is advised during and for a time after treatment.

Tamoxifen Side Effects

Common side effects

Common tamoxifen side effects include hot flashes, night sweats, flushing, vaginal dryness or discharge, menstrual irregularities in premenopausal women, mild nausea, fluid retention, ankle swelling, leg cramps, fatigue, mood changes and weight fluctuations. Some patients report changes in libido, sleep disturbances or mild hair thinning and nail changes. These symptoms often reflect systemic shifts in estrogen activity caused by Tamodex tamoxifen tablets.

Many of these common tamoxifen side effects can be managed with lifestyle strategies such as layered clothing, cooling measures for hot flashes, non-hormonal options for vasomotor symptoms, local treatments for vaginal dryness, gentle exercise, sleep hygiene and psychological support. The treating team may suggest additional non-hormonal medications to help control troublesome menopausal-type symptoms, always balancing relief with overall safety.

Serious side effects

Serious tamoxifen adverse effects are less frequent but require immediate medical attention. These include symptoms of deep vein thrombosis (unilateral leg swelling, pain, redness, warmth), pulmonary embolism (acute chest pain, sudden shortness of breath, coughing up blood), stroke or transient ischaemic attack (sudden weakness, facial droop, difficulty speaking, loss of vision), signs of endometrial pathology (persistent or heavy vaginal bleeding, pelvic pain) and signs of significant liver injury (dark urine, severe itching, yellowing of skin or eyes). Sudden severe visual changes should also prompt urgent evaluation.

If any of these warning signs occur while taking Tamodex tamoxifen tablets, emergency assessment is essential. The medical team may need to stop tamoxifen, investigate with imaging and laboratory tests, treat complications such as clots or bleeding, and reconsider the future endocrine strategy.

Storage

Tamodex 10 mg and 20 mg tamoxifen tablets should be stored in their original blister strips at room temperature, generally below 25–30 °C, and kept dry and away from direct sunlight or heat sources. Tablets should not be transferred into unlabelled containers or mixed with other medicines in weekly boxes without clear instructions from a pharmacist, as this can increase the risk of dosing errors. Packs must be stored out of the sight and reach of children. Any tablets that appear damaged, discoloured or are past the expiry date should be discarded according to local guidance for medicine disposal.

Why Buy from Generic Meds Mart

Generic Meds Mart is focused on structured access to essential oncology and endocrine therapies, including Tamodex tamoxifen tablets. We work only with licensed manufacturers and authorised distributors who provide full batch traceability and adhere to Good Manufacturing Practice standards. Each Tamodex 10 mg or 20 mg pack is supplied in sealed original packaging, allowing clinics and pharmacies to verify authenticity, batch numbers and expiry dates before dispensing.

By listing Tamodex pricing in USD and offering 1 pack / 100 tabs formats, we help patients and clinics plan long-term tamoxifen therapy, which often spans several years. Neutral outer packaging and discrete shipping options support privacy, while tracking (where available) helps coordinate deliveries with clinic visits and prescription renewals. Our role is limited to access and logistics; all clinical decisions about Tamodex tamoxifen use, monitoring and duration remain strictly with your treating professionals.

Order Now

Tamodex 10 mg and 20 mg tamoxifen tablets are powerful components of hormone receptor–positive breast cancer treatment and prevention. They must never be started, adjusted or stopped without guidance from an oncologist or breast specialist. Before ordering through Generic Meds Mart, ensure that your diagnosis or risk profile, overall treatment plan and intended duration of tamoxifen therapy have been fully discussed and documented with your care team.

Once a clear plan is in place, you or your clinic can calculate how many Tamodex 10 mg and Tamodex 20 mg packs (1 pack / 100 tabs) are needed for the next treatment interval. Select the appropriate strengths and quantities on Generic Meds Mart, add them to your cart and complete secure checkout in USD. Medicines will be dispatched in discreet outer packaging with original blisters inside. Any new symptoms, side effects or concerns during tamoxifen therapy should always be discussed promptly with your treating team rather than managed by self-adjusting the dose.

FAQ about Tamodex (Tamoxifen)

Q1: What is Tamodex used for?
Tamodex contains tamoxifen citrate, a selective estrogen receptor modulator used mainly in hormone receptor–positive breast cancer treatment, both in early and metastatic disease, and in some high-risk women to lower future breast cancer risk in line with guideline recommendations.

Q2: Is Tamodex a chemotherapy medicine?
Tamodex tamoxifen tablets are not classical cytotoxic chemotherapy. They are a hormonal or endocrine therapy that targets estrogen signalling in breast tissue. Nonetheless, tamoxifen is as crucial as chemotherapy in many treatment plans and requires specialist supervision and regular follow-up.

Q3: How long do patients usually take Tamodex?
Many patients with hormone receptor–positive early breast cancer take tamoxifen for at least 5 years, with some benefiting from extended courses up to 10 years or from sequential endocrine strategies. Preventive courses in high-risk women also typically last several years. The exact duration is tailored by your oncology or breast care team.

Q4: Can antidepressants or other medicines interfere with Tamodex?
Certain antidepressants and other drugs can affect tamoxifen metabolism and may influence how much active metabolite is formed. Always provide your doctor and pharmacist with an up-to-date list of all medicines and supplements so they can choose options compatible with Tamodex tamoxifen tablets or adjust treatment if needed.

Q5: Do I need contraception while on Tamodex?
Tamoxifen can harm an unborn baby and is not a contraceptive. Women who could become pregnant are usually advised to use reliable non-hormonal contraception during treatment and for a period after stopping Tamodex, as recommended by their specialist.

Imat Imatinib – 100 mg, 400 mg (1 pack / 10 tabs) Tablets

At a Glance

Brand name: Imat

Generic name: Imatinib mesylate

Active ingredient: Imatinib

Strengths & packs: Imat 100 mg (1 pack / 10 tablets); Imat 400 mg (1 pack / 10 tablets)

Dosage form: Oral film-coated tablets

Main indication: Philadelphia chromosome–positive chronic myeloid leukemia (CML) and selected GIST

Therapeutic class: Tyrosine kinase inhibitor (TKI)

Use in therapy: First-line and subsequent targeted therapy for Ph+ CML and indicated solid tumors

Prescription status: Prescription-only anticancer medicine

Supplied by: Licensed manufacturers and authorised distributors

Storage: Store below 25 °C in a dry place, protected from moisture and light

Product Description

Imat 100 mg and Imat 400 mg tablets are
generic imatinib mesylate medicines used as part of targeted therapy for specific blood cancers and solid tumors.
Imatinib is a tyrosine kinase inhibitor (TKI) that has transformed the management of
Philadelphia chromosome–positive chronic myeloid leukemia (CML) and many gastrointestinal stromal tumors (GIST).
This variable product listing combines both strengths so you can buy Imat online in either
100 mg (1 pack / 10 tablets) or 400 mg (1 pack / 10 tablets) according to your specialist’s prescription.

Imat imatinib tablets are commonly prescribed as long-term daily therapy. In chronic phase CML,
imatinib tablets can help control leukemic cell counts, maintain remission and support long-term disease control.
Imat 100 mg tablets are useful when flexible dosing or smaller adjustments are needed, while
Imat 400 mg tablets offer a convenient standard-dose option. Because
Imat is a generic imatinib product, it contains the same active ingredient as branded imatinib but is often available at more accessible USD pricing,
which is important for extended treatment courses.

Each Imat tablet contains imatinib mesylate corresponding to the stated strength of imatinib (100 mg or 400 mg).
The tablets are taken orally with water, usually once daily or split into two doses, depending on the total daily dose and tolerability.
When you order Imat online from Generic Meds Mart, you receive imatinib tablets supplied by licensed manufacturers and authorised distributors
that follow recognised Good Manufacturing Practice standards. Original packaging retains full product details, while outer shipping materials are plain and discreet.

This Imat 100 mg (1 pack / 10 tabs) / 400 mg (1 pack / 10 tabs) product is intended only for patients under the care of a haematologist or oncologist
who has clearly recommended imatinib therapy. Generic Meds Mart does not provide diagnosis or change treatment plans;
this page is designed to support informed discussions with your specialist about access to generic imatinib tablets.

Key Uses

Imat imatinib tablets are generally used for the following indications under specialist supervision:

• Treatment of Philadelphia chromosome–positive chronic myeloid leukemia (CML) in chronic, accelerated or blast phase as directed
• Treatment of Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ ALL) in selected cases
• Treatment of metastatic and/or unresectable gastrointestinal stromal tumors (GIST) expressing KIT (CD117)
• Treatment of other rare malignancies where imatinib is specifically recommended in recognised protocols

Your specialist will determine whether Imat 100 mg or Imat 400 mg is appropriate, how many tablets you should take per day and
how long imatinib therapy should continue.

How Imatinib Works in Chemotherapy

Imatinib is a targeted anticancer agent often grouped within modern systemic chemotherapy and targeted therapy regimens.
Imat contains imatinib, a tyrosine kinase inhibitor (TKI) that blocks abnormal signalling from specific tyrosine kinases such as BCR-ABL in CML
and KIT in many GIST tumours.

Imat imatinib tablets work by binding to these overactive tyrosine kinases and blocking their ATP-binding sites.
This disrupts signalling pathways that drive uncontrolled cancer cell growth and survival. In
chronic myeloid leukemia, this targeted inhibition can reduce leukemic cell counts and support long-term remission.
In GIST, inhibition of KIT can shrink or stabilise tumours that depend on this pathway.

Because imatinib acts as a targeted TKI rather than a traditional cytotoxic drug, its side effect profile differs from standard chemotherapy.
However, Imat is still a potent anticancer medicine and must be monitored carefully by an experienced haematologist or oncologist.

Dosage & Administration

Imat 100 mg and Imat 400 mg imatinib tablets must always be taken exactly as prescribed by your specialist.
Daily dosing, timing and duration of therapy depend on your diagnosis, disease phase, response and tolerance.

• Take Imat tablets by mouth with a large glass of water; some patients are advised to take doses with food to reduce stomach discomfort.
• Swallow the tablets whole. Do not crush, split or chew Imat tablets unless your doctor or pharmacist has given specific instructions.
• The total daily dose may be taken once daily or divided into two doses, depending on your prescription and tolerance.
• Do not change your dose, switch between Imat 100 mg and Imat 400 mg, or stop taking imatinib without clear instructions from your specialist.
• If you miss a dose, follow your doctor’s advice; do not double the next dose to make up for a missed tablet unless your oncologist has recommended it.

Your haematologist or oncologist will schedule regular blood tests and other assessments to monitor your response to
Imat imatinib therapy and adjust doses if needed.

Precautions

Before starting Imat, inform your doctor about your complete medical history and all medicines, supplements or herbal products you use. Important considerations include:

• History of liver disease, kidney impairment or significant cardiac disease
• Pre-existing fluid retention, swelling, heart failure or shortness of breath
• Previous or current gastrointestinal bleeding, ulcers or major stomach or bowel disease
• Use of other anticancer medicines, immunosuppressants or biologic therapies
• Use of strong CYP3A4 inhibitors or inducers, certain antibiotics, antifungals or antiepileptics that may interact with imatinib
• Use of paracetamol, anticoagulants or other medicines that may require careful monitoring with Imat imatinib tablets

Imatinib may not be suitable during pregnancy, and effective contraception is usually recommended during treatment and for a period afterwards, as advised by your doctor.
Breastfeeding is often discouraged while taking Imat. Your specialist will set an appropriate monitoring schedule in your case.

Imatinib Side Effects

Common side effects

Many patients experience side effects when starting Imat imatinib tablets, especially during the first months of treatment. Common reactions may include:

• Nausea, mild vomiting or stomach discomfort
• Diarrhea or, in some cases, constipation
• Fluid retention with swelling of ankles, legs or around the eyes
• Muscle cramps, bone pain or joint discomfort
• Fatigue, weakness or general tiredness
• Mild skin rash or itching

These side effects are often manageable with supportive care or dose adjustments, but you should report persistent or troublesome symptoms to your oncology team.

Serious side effects

Some side effects of imatinib are less common but more serious and require urgent medical attention. Serious reactions may include:

• Marked fluid retention with sudden weight gain, worsening shortness of breath or pronounced leg swelling
• Signs of severe liver problems, such as yellowing of the skin or eyes, dark urine, pale stools or intense upper abdominal pain
• Severe abdominal pain, bloody stools or vomiting blood, which may indicate serious gastrointestinal issues
• Significant changes in blood counts, with fever, frequent infections, unusual bruising or prolonged bleeding
• Severe skin reactions, widespread rash, blistering or involvement of the mouth or eyes

If you experience any of these serious symptoms while taking Imat 100 mg or Imat 400 mg, seek immediate medical care and contact your specialist as soon as possible.

Storage

• Store Imat tablets at room temperature, usually below 25 °C, in a dry place away from direct sunlight and excess heat.
• Keep the tablets in their original blisters and cartons until use to protect them from moisture and light.
• Keep Imat imatinib tablets out of the sight and reach of children and pets.
• Do not use the medicine after the expiry date printed on the packaging.

Ask your pharmacist or follow local regulations for safe disposal of unused or expired imatinib tablets.

Why Buy from Generic Meds Mart

Generic Meds Mart focuses on providing reliable access to essential oncology medicines such as
Imat 100 mg and Imat 400 mg imatinib tablets at fair prices in USD.
We work only with licensed manufacturers and authorised distributors that comply with recognised GMP standards and maintain a documented export track record.

When you buy Imat online from Generic Meds Mart, you benefit from:

• Competitive pricing on generic imatinib tablets compared with many local pharmacies
• Discreet, plain packaging designed to protect your privacy during shipping
• Tracked international delivery options to many destinations
• Clear, structured product information to support discussions with your haematologist or oncologist
• Customer support available to assist with ordering, payment and shipping questions

Our goal is to help you maintain continuity of prescribed targeted therapy with transparent conditions and professional handling of each order.

Order Now

Imat 100 mg and 400 mg imatinib tablets are prescription-only anticancer medicines and must be used strictly under the supervision of a haematologist or oncologist.
Before you order Imat online, ensure that you have a valid prescription or written treatment plan specifying imatinib, the required daily dose and intended duration of therapy.

Select the prescribed strength — Imat 100 mg (1 pack / 10 tablets) or Imat 400 mg (1 pack / 10 tablets) —
choose the appropriate quantity, add Imat to your cart and complete the secure checkout process. Your order will be processed, packed discreetly and shipped with tracking where available.

Generic Meds Mart does not provide diagnosis or personalised medical advice. All treatment decisions, dose changes and monitoring remain the responsibility of your oncology team.

Spnib 100 mg Dasatinib Tablets (1 bottle / 30 tabs)

At a Glance

Generic Name: Dasatinib

Brand Name: Spnib 100 mg

Strength & Pack Size: 100 mg tablets, 1 bottle / 30 tablets

Dosage Form & Route: Oral film-coated tablets for swallowing whole with water

Therapeutic Class: Second-generation BCR-ABL tyrosine kinase inhibitor and SRC family kinase inhibitor

Primary Indications: Philadelphia chromosome–positive chronic myeloid leukemia (CML) and Ph+ acute lymphoblastic leukemia (ALL), according to local label

Typical Use in Therapy: Used as first- or subsequent-line TKI option in Ph+ CML or Ph+ ALL under specialist protocols

Mode of Action: Inhibits BCR-ABL and other kinases to block abnormal signalling and leukemic cell proliferation

Key Benefits: Active in many patients resistant or intolerant to imatinib, with rapid and deep molecular responses in appropriately selected cases

Precautions: Myelosuppression, bleeding, fluid retention, pulmonary arterial hypertension and QT prolongation require close monitoring

Storage: Store below 25 °C in the original container, tightly closed and protected from moisture

Product Description

Spnib 100 mg contains dasatinib, an oral second-generation tyrosine kinase inhibitor used in the treatment of Philadelphia chromosome–positive leukemias. It is typically prescribed for Ph+ chronic myeloid leukemia (CML) and Ph+ acute lymphoblastic leukemia (ALL) in adults when a potent BCR-ABL inhibitor is needed, including situations where imatinib has failed due to resistance or intolerance, or where local protocols support dasatinib in earlier lines of therapy.

Each bottle of Spnib 100 mg supplied by Generic Meds Mart contains 30 film-coated dasatinib tablets. The 100 mg strength is commonly used in adult regimens, although the exact dose and schedule are always determined by a hematologist or oncologist based on disease phase, prior treatment, concomitant medicines and the patient’s overall health. Spnib 100 mg dasatinib tablets are taken by mouth, usually once daily, and are intended for long-term use as part of a continuous tyrosine kinase inhibitor strategy for Ph+ CML or Ph+ ALL where clinically appropriate.

Generic Meds Mart works only with licensed manufacturers and authorised distributors for oncology TKIs like Spnib 100 mg. Bottles are supplied in original, sealed packaging so that treating centres can verify brand, strength, batch number and expiry before dispensing. Outer shipping cartons are neutral, without visible references to leukemia or dasatinib, helping to protect patient privacy during international delivery. Prices are displayed in USD to make long-term therapy planning more transparent for patients and clinics.

Key Uses

Spnib 100 mg dasatinib tablets are used for guideline-based indications in Philadelphia chromosome–positive leukemias, according to local product information and specialist recommendations. In clinical practice, this typically includes:

Spnib 100 mg as a second-generation BCR-ABL inhibitor in adults with Ph+ CML, including chronic, accelerated or blast phase disease where dasatinib is considered appropriate by the treating team.

Spnib 100 mg in adults with Ph+ ALL when a potent oral TKI is required in induction, consolidation or maintenance phases alongside multi-agent chemotherapy or other targeted regimens, based on protocol.

Depending on region and label, dasatinib may be used either after imatinib failure or intolerance, or as a first-line option in selected patients. The decision to use Spnib 100 mg, and its position relative to other TKIs such as imatinib or nilotinib, must always be made by an experienced hematologist working within evidence-based guidelines.

How Dasatinib Works in Chemotherapy

Dasatinib, the active ingredient in Spnib 100 mg, is a potent inhibitor of the BCR-ABL tyrosine kinase, the abnormal fusion protein generated by the Philadelphia chromosome translocation t(9;22). This fusion kinase drives uncontrolled proliferation and survival of leukemic cells in Ph+ CML and Ph+ ALL.

By binding to and inhibiting BCR-ABL, dasatinib blocks downstream signalling pathways that support leukemic cell division and resistance to apoptosis. Dasatinib also inhibits other kinases, including members of the SRC family, which may contribute to its activity in leukemic cells. Compared with first-generation TKIs, dasatinib has broader binding characteristics and can retain activity against many imatinib-resistant BCR-ABL mutations, although some mutations remain problematic.

In clinical use, effective inhibition of BCR-ABL by Spnib 100 mg dasatinib tablets can lead to rapid reductions in leukocyte counts, improved bone marrow morphology and achievement of cytogenetic and molecular responses. Achieving and maintaining deep molecular responses is associated with better long-term outcomes in Ph+ CML and Ph+ ALL when managed according to specialist protocols.

Dosage & Administration

Spnib 100 mg must be prescribed and monitored by a hematologist or oncologist experienced in managing Ph+ leukemias. The usual adult dose and schedule are defined in the official product information and may vary according to indication, disease phase, prior therapies and local practice. Tablets are swallowed whole with water and should not be crushed or chewed.

Dasatinib can be taken with or without food, but patients should follow the exact instructions given by their treatment centre. Certain medicines, including proton pump inhibitors and strong CYP3A4 inhibitors or inducers, can affect dasatinib exposure and may need to be avoided or adjusted. Regular blood counts, liver function tests and clinical assessments are required to monitor response and toxicity. Dose interruptions, reductions or switches to an alternative TKI may be necessary in cases of significant myelosuppression, fluid retention, pulmonary events or other adverse effects. Patients should never change their Spnib 100 mg dose without specialist advice.

Precautions

Before starting Spnib 100 mg dasatinib tablets, the treatment team will review the patient’s medical history, ECG, cardiovascular status, liver and kidney function, concomitant medicines and bleeding risk. Dasatinib can cause myelosuppression, including neutropenia, thrombocytopenia and anemia, so frequent full blood count monitoring is essential, particularly in the first months of therapy.

Important precautions described in dasatinib prescribing information include risks of serious bleeding, fluid retention (such as pleural effusion and pericardial effusion), pulmonary arterial hypertension, QT interval prolongation and hepatotoxicity. Caution is required in patients with prior heart disease, uncontrolled hypertension, lung disease, liver impairment or those taking other QT-prolonging drugs. Women who are pregnant or may become pregnant should not handle dasatinib tablets without protection, and effective contraception is recommended for patients of reproductive potential.

Dasatinib Side Effects

Common side effects

Common dasatinib side effects in patients taking Spnib 100 mg include myelosuppression with low white cells, low platelets or anemia; headache; fatigue; nausea; vomiting; diarrhoea; abdominal discomfort; rash; musculoskeletal pain; mild fluid retention such as ankle swelling; and mild elevations in liver enzymes. Some patients experience cough or shortness of breath, which may be related to fluid around the lungs and must be assessed by the treating team.

These effects are often manageable with temporary treatment interruption, dose reduction, supportive therapy such as transfusions or growth factors and careful monitoring. Patients should attend all scheduled blood tests and clinic visits so that emerging issues can be detected early.

Serious side effects

Serious dasatinib adverse effects require urgent medical attention. These may include severe thrombocytopenia or neutropenia with increased risk of bleeding or infection; major haemorrhage; significant pleural or pericardial effusion; signs of pulmonary arterial hypertension such as progressive shortness of breath and fatigue; marked fluid overload; severe liver injury with jaundice; and serious cardiac events or marked QT prolongation.

Patients should contact emergency services or their treating centre immediately if they experience chest pain, severe shortness of breath, sudden swelling, black or bloody stools, coughing up blood, high fever, uncontrolled bleeding, confusion, severe dizziness or fainting. The treating team may need to interrupt Spnib 100 mg, adjust the dose or switch to an alternative therapy depending on the severity and type of adverse event.

Storage

Spnib 100 mg dasatinib tablets should be stored in the original, tightly closed bottle below 25 °C, protected from moisture and heat. The bottle should be kept out of the sight and reach of children and should not be stored in very humid environments such as bathrooms. Tablets must not be used after the expiry date shown on the label and carton. Unused or expired tablets should be returned to a pharmacy or disposed of in accordance with local oncology waste guidelines, not placed in household rubbish or wastewater.

Why Buy from Generic Meds Mart

Generic Meds Mart is focused on structured access to specialist oral oncology medicines such as Spnib 100 mg dasatinib tablets. We source only from licensed manufacturers and authorised distributors who comply with Good Manufacturing Practice and maintain traceable batch records. Each bottle of Spnib 100 mg is supplied in sealed, original packaging so pharmacists and clinicians can verify brand name, strength, batch number and expiry before dispensing to patients.

Orders placed through Generic Meds Mart are billed in USD, simplifying cost planning for long-term TKI therapy. Shipments are packed in neutral outer cartons with no explicit mention of leukemia, dasatinib or Spnib 100 mg, and where available, tracking information is provided so that patients and clinics can coordinate refills before existing supplies run out. Our support team can help with ordering and logistics questions, while all decisions about whether to use a specific tyrosine kinase inhibitor remain exclusively with your hematology or oncology team.

Order Now

Spnib 100 mg dasatinib tablets are a potent, targeted therapy for Philadelphia chromosome–positive leukemias and must not be started without a detailed plan from an experienced specialist. Before you buy Spnib 100 mg online from Generic Meds Mart, ensure that your diagnosis, BCR-ABL status, prior TKI exposure and overall treatment goals have been fully discussed with your hematologist. You should have clear instructions about your daily dose, timing, monitoring schedule and what to do if doses are missed or side effects occur.

Once your plan is in place, your team can calculate how many bottles of Spnib 100 mg (1 bottle / 30 tabs) are needed for the initial treatment period. You can then select the appropriate quantity on Generic Meds Mart, add it to your cart and complete secure checkout in USD. Your medicine will be shipped in discreet packaging with full product labelling. You should never change, pause or stop dasatinib therapy on your own; any new or severe symptoms must be discussed promptly with your specialist team, and emergency services should be contacted when serious warning signs appear.

FAQ about Spnib (Dasatinib)

Q1: What is Spnib 100 mg used for?
Spnib 100 mg contains dasatinib, a second-generation BCR-ABL tyrosine kinase inhibitor used under specialist supervision for Philadelphia chromosome–positive chronic myeloid leukemia (CML) and Ph+ acute lymphoblastic leukemia (ALL), according to local approvals and guidelines.

Q2: How should I take Spnib 100 mg tablets?
Spnib 100 mg dasatinib tablets are usually taken once daily, swallowed whole with water. You should follow the exact dose and timing given by your hematologist and avoid crushing or chewing the tablets. If you miss a dose, follow the instructions in your product leaflet or contact your clinic rather than doubling up the next day.

Q3: Will I need regular blood tests while on dasatinib?
Yes. Dasatinib can cause myelosuppression and other laboratory changes, so regular full blood counts and chemistry tests are essential, especially early in treatment. Your team will use these results to adjust your dose, pause therapy or provide supportive care if necessary.

Q4: Can Spnib 100 mg interact with other medicines?
Dasatinib is metabolised by CYP3A4 and can interact with many medicines, including certain antifungals, antibiotics, antivirals, anticonvulsants and stomach acid–reducing drugs. You should provide a full list of all prescription, over-the-counter and herbal products to your specialist, and never start or stop any medicine without checking for potential interactions.

Q5: How long will I need to stay on Spnib 100 mg?
Treatment duration with Spnib 100 mg dasatinib tablets is highly individual. Many patients remain on therapy for years to maintain deep molecular responses, while others may switch TKIs or change strategy if responses are suboptimal or side effects are problematic. Your hematologist will review your response milestones and overall health to decide whether to continue, adjust or change treatment over time.

6-MP 50 mg Mercaptopurine Tablets (1 pack / 100 tabs)

At a Glance

Generic Name: Mercaptopurine

Brand Name: 6-MP

Strength & Pack Size: 50 mg per tablet; 1 pack / 100 tablets

Dosage Form & Route: Oral tablet, taken by mouth with water as prescribed

Therapeutic Class: Antimetabolite (thiopurine), cytotoxic anticancer medicine

Primary Indication: Acute lymphoblastic leukemia (ALL) maintenance therapy as part of a specialist-directed regimen

Usual Adult Dose: Individualised dosing based on protocol, body size and blood counts; follow your oncology team’s plan

Prescription Status: Prescription-only medicine

Storage: Store at room temperature in the original packaging, protected from moisture and light

Product Description

6-MP 50 mg contains mercaptopurine, a thiopurine antimetabolite used as part of maintenance therapy for acute lymphoblastic leukemia (ALL) and other protocol-defined settings in hematology–oncology care. This product is supplied as 50 mg tablets in a 1 pack / 100 tabs presentation to support planned treatment cycles and ongoing monitoring. Mercaptopurine is a prescription-only cytotoxic medicine and must only be used within a confirmed diagnosis and a regimen designed by a qualified specialist.

In ALL care, maintenance therapy is structured and long-term, and it depends on careful dose adjustment rather than a one-size-fits-all approach. Your treating team considers age, body size, liver function, infection risk, prior therapy, and laboratory trends when selecting a mercaptopurine dose. The goal is to maintain effective therapy while keeping side effects manageable through planned monitoring. Because mercaptopurine can significantly affect blood counts and liver tests, scheduled follow-up is an essential part of treatment, even when you feel well.

Generic Meds Mart supplies 6-MP 50 mg mercaptopurine tablets in original packaging sourced through licensed channels. Packs typically show the brand name, strength, active ingredient, batch number, and expiry date so your pharmacy or clinic can verify the product on receipt. Orders are processed with secure checkout in USD and shipped in discreet outer packaging to support privacy. If you are comparing options, ask your clinic to confirm the correct strength and pack size before ordering, and avoid making decisions based only on mercaptopurine price.

Key Uses 6-MP (Mercaptopurine) for Acute Lymphoblastic Leukemia (ALL) Maintenance Therapy

6-MP 50 mg mercaptopurine is primarily used in acute lymphoblastic leukemia maintenance therapy under specialist supervision. Maintenance therapy is commonly used after induction and consolidation phases to help sustain remission, and it is usually combined with other medicines according to the protocol selected by your hematology–oncology team. The exact combination, schedule, and duration depend on the specific treatment plan and regional guidelines.

Mercaptopurine may also be used in other carefully defined hematology settings where thiopurines are part of an established protocol. The indication and dosing are always defined by the treating specialist, because the balance between benefit and risk depends on blood count monitoring, liver function monitoring, and assessment of infection risk. If you need to order mercaptopurine tablets online, ensure you have written instructions from your clinic covering dosing, missed-dose rules, and the frequency of required lab tests.

How Mercaptopurine Works in Chemotherapy

Mercaptopurine is an antimetabolite that interferes with the synthesis of nucleic acids, which are essential for cell replication and growth. After it is taken by mouth, mercaptopurine is converted into active metabolites that can disrupt the production and function of DNA and RNA. Leukemia cells, which divide and renew rapidly, may be particularly affected when these pathways are inhibited, helping maintenance therapy support long-term disease control in protocol-based care.

Because mercaptopurine targets fundamental cellular processes, it can also affect some normal rapidly dividing cells, especially in the bone marrow. This is why blood counts must be monitored and why dosing is often adjusted over time. The same mechanism that supports therapeutic effect can also contribute to side effects such as neutropenia or anemia, and your specialist uses regular lab monitoring to keep treatment within safe limits while maintaining the intended regimen.

Dosage & Administration

6-MP 50 mg tablets are taken by mouth exactly as prescribed by a hematology–oncology specialist. Dosing is typically individualized and adjusted based on treatment protocol, body size, blood counts, liver function tests, and clinical tolerance. Your clinic may provide specific instructions about the time of day to take mercaptopurine and whether to take it with food, and it is important to follow the same routine consistently unless your specialist advises a change.

Swallow the tablet with water and do not change the dose on your own. Never take extra tablets to “catch up” after a missed dose unless your clinic explicitly instructs you to do so. Drug interactions can be clinically important, and certain medicines can increase the risk of side effects, so always share a complete list of prescriptions, over-the-counter products, and supplements with your healthcare team. If you are unsure how to take a dose on a day you feel unwell, contact your treating team rather than adjusting the medicine yourself.

Precautions

Mercaptopurine can cause significant bone marrow suppression, leading to low white blood cells, low platelets, and anemia. This increases the risk of infection and bleeding, and it is why regular blood tests are required during therapy. Fever, chills, persistent sore throat, mouth ulcers, unusual bruising, bleeding, or shortness of breath should be reported urgently to your clinic so you can be assessed promptly.

Liver-related side effects are also possible, and your specialist will typically monitor liver enzymes and other laboratory markers. You should tell your team if you develop yellowing of the skin or eyes, dark urine, severe nausea, persistent vomiting, or right-sided abdominal pain. Because immune suppression may increase the risk of infections, your clinic may advise practical precautions and may review vaccines and exposure risks based on your situation.

Mercaptopurine may harm an unborn baby, so pregnancy should be avoided during treatment and contraception planning should be discussed with your specialist. Do not start new medicines without checking with your treating team, especially medicines that may affect the immune system or liver function. Your clinic will define the monitoring plan and may adjust treatment based on blood counts, liver tests, and your overall response.

Mercaptopurine Side Effects

Common side effects

Common mercaptopurine side effects may include nausea, decreased appetite, mild stomach discomfort, tiredness, and changes in blood tests such as lowered blood counts or mild liver enzyme elevations. Some people notice increased susceptibility to infections because of reduced white blood cells, and minor mouth soreness can occur. These effects are often managed by monitoring, supportive care, and dose adjustments within the specialist-led plan, and you should report ongoing symptoms rather than altering the dose independently.

Serious side effects

Serious side effects require urgent medical attention and may include severe neutropenia with fever, serious infections, significant bleeding or bruising from low platelets, severe anemia with marked weakness or shortness of breath, and signs of significant liver injury such as jaundice or dark urine. Severe abdominal pain, persistent vomiting, or rapidly worsening weakness should be assessed promptly. If you develop high fever, confusion, chest pain, uncontrolled bleeding, or severe shortness of breath, seek urgent care and tell clinicians you are receiving mercaptopurine.

Storage

Store 6-MP 50 mg mercaptopurine tablets at room temperature in the original packaging, protected from moisture and direct light. Keep the pack tightly closed if supplied in a bottle, and keep all medicines out of reach of children and pets. Do not use the tablets after the expiry date printed on the packaging. If your clinic provides specific handling guidance for cytotoxic medicines in the home, follow it carefully, and ask your pharmacist about safe disposal of unused tablets.

Why Choose Generic Meds Mart for Your 6-MP (Mercaptopurine) Supply?

We bridge the gap between your doctor’s prescription and reliable access to essential medication.

Our Role: We are a reliable supplier, not a substitute for your medical team.

Mercaptopurine requires specialist monitoring and careful dose adjustment, and Generic Meds Mart does not replace your treating doctor. Decisions about whether mercaptopurine is appropriate, how it fits into your protocol, and how to manage side effects must be made by qualified healthcare professionals. Our role is to help you obtain the medicine your clinic has prescribed and to support predictable access for ongoing therapy.

Order Now

Before you buy 6-MP 50 mg online from Generic Meds Mart, you should have a confirmed diagnosis and a mercaptopurine-based plan agreed with your hematology–oncology team. Your clinic will advise how often you need blood counts and liver function tests, how missed doses should be handled, and what symptoms require urgent contact. Once your plan is confirmed, select 6-MP 50 mg (1 pack / 100 tabs), add it to your cart, and complete secure checkout in USD.

Do not start mercaptopurine on your own and do not change dosing without medical guidance. If you develop fever, signs of infection, unusual bleeding, severe weakness, or symptoms that suggest liver problems, contact your clinic urgently or seek emergency care and inform clinicians that you are taking mercaptopurine.

FAQ about 6-MP (Mercaptopurine)

Q1: What is 6-MP 50 mg used for?

6-MP 50 mg contains mercaptopurine, an antimetabolite medicine used mainly as part of specialist-directed maintenance therapy for acute lymphoblastic leukemia (ALL) according to a defined treatment protocol.

Q2: How do I take mercaptopurine tablets?

Mercaptopurine tablets are taken by mouth on a schedule prescribed by your hematology–oncology team. Swallow the tablet with water and follow your clinic’s instructions about timing and consistency, and never self-adjust the dose.

Q3: Why are regular blood tests needed during treatment?

Mercaptopurine can lower blood counts and affect liver tests, so regular monitoring helps your specialist adjust dosing safely and detect problems early. This monitoring is a key part of maintenance therapy planning.

Q4: What should I do if I miss a dose?

Follow your clinic’s written instructions for missed doses and do not take extra tablets unless your treating team specifically tells you to. If you are unsure, contact your prescribing team for guidance.

Q5: What symptoms should be treated as urgent during mercaptopurine therapy?

Fever, chills, sore throat, unusual bruising or bleeding, severe weakness, shortness of breath, or signs of liver problems such as jaundice should be reported urgently. If symptoms are severe or rapidly worsening, seek emergency care and tell clinicians you are taking mercaptopurine.